Korro Bio, Inc.
KRRO
$10.18
-$0.90-8.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -19.63M | -50.04M | -18.06M | -25.77M | -23.39M |
| Total Depreciation and Amortization | 380.00K | 649.00K | 1.18M | 1.23M | 1.23M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.98M | 33.14M | 1.96M | 2.17M | 1.58M |
| Change in Net Operating Assets | 196.00K | -1.45M | -2.25M | 3.15M | -3.87M |
| Cash from Operations | -16.07M | -17.70M | -17.18M | -19.23M | -24.45M |
| Capital Expenditure | -21.00K | -84.00K | -175.00K | -140.00K | -119.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -32.22M | 15.00M | 7.77M | -11.16M | 32.90M |
| Cash from Investing | -32.24M | 14.92M | 7.60M | -11.30M | 32.78M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 88.21M | 380.00K | 128.00K | 5.00K | 172.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 88.21M | 380.00K | 128.00K | 5.00K | 172.00K |
| Foreign Exchange rate Adjustments | -25.00K | 75.00K | -2.00K | -9.00K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 39.87M | -2.33M | -9.46M | -30.53M | 8.50M |